Rule 10b-5 prohibits deceit or manipulation in connection with any purchase or sale of a security registered or traded on an exchange and is enforced through the SEC and private lawsuits. The rule targets misrepresentations, omissions of material facts, and other fraudulent schemes designed to affect a security’s price.
In enforcement and litigation, Rule 10b-5 claims are used to pursue securities fraud cases. The U.S. Securities and Exchange Commission (SEC) can bring civil actions, and private investors may file lawsuits. Courts examine whether a defendant engaged in fraud or deceit, and whether the conduct was tied to a sale or purchase of a security in interstate commerce.
Typical elements include a misrepresentation or omission of a material fact, scienter (intent or knowledge of wrongdoing), reliance on the misstatement, causation, and damages. The fraud-on-the-market theory allows courts to infer reliance for publicly traded securities when the market price reflects the misrepresented information.
Rule 10b-5 is a central tool in federal securities law used to deter and remedy securities fraud, shaping corporate disclosure practices and the behavior of issuers, directors, and market participants.
An investor sues after learning that a company's public earnings statement overstated results, arguing the misrepresentation violated Rule 10b-5.
Securities fraud · Section 10(b) of the Securities Exchange Act of 1934 · Misrepresentation · Omission of material fact · Insider trading · Fraud-on-the-market theory · Private right of action